Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Odontol. pediatr. (Lima) ; 9(1): 61-70, ene.-jun. 2010. ilus, tab, graf
Article in Spanish | LILACS, LIPECS | ID: lil-565345

ABSTRACT

Introducción: El Anaeject® es una nueva jeringa anestésica de la cual existen pocos estudios clínicos. La característica principal de esta jeringa es que administra la cantidad anestésica precisa mediante la inyección sin presión excesiva, evitando el dolor. Objetivo: El propósito de este estudio es comparar la medida de la frecuencia cardíaca producida en el paciente y la intensidad del dolor percibida durante la inyección, mediante la aplicación del sistema Anaeject® o de la jeringa convencional. Material y métodos: 20 pacientes de edades comprendidas entre 4 y 9 años de la Universitat Internacional de Catalunya (Barcelona, España), que requerían como mínimo 2 tratamientos que necesitas en la aplicación de la misma técnica anestésica participaron en el estudio. El orden de aplicación de Anaeject® o de la jeringa convencional se realizó al azar, dividiendo a los niños en 2 grupos según la aplicación. Se aplicaron diferentes escalas y se evaluó la frecuencia cardiaca en diferentes momentos del tratamiento. Resultados: Los resultados fueron analizados mediante el sistema estadístico-informático Statgraphics Plus® Version 5.0, utilizándose la técnica de ANOVA multifactorial para el análisis de los datos subjetivos y el test de la t de Student de muestras pareadas para los datos objetivos. No se encontraron diferencias estadísticamente significativas (p menor que 0.05) en cuanto a la medida de la frecuencia cardíaca y al dolor percibido durante la inyección. Conclusiones: La utilización del sistema Anaeject® no disminuye el dolor percibido por parte del paciente durante la inyección, comparado con la jeringa convencional.


Background: Anaeject® is a new anesthetic syringe. However, very few clinical studies have been carried out on it. The main characteristic of this syringe is that it administers the exact amount of anesthetic need bye means of an injection, without excessive pressure, which avoids pain. Objetive: The aim of this study was to compare the anxiety in patients and the intensity of the pain perceived during injection, that arise from using the Anaeject® system and the conventional syringe system. Material and methods: The study group consisted of 20 patients of the International University of Catalonia (Barcelona, Spain), aged between 4 and 9 years, who needed a minimum of 2 treatments that required the same anesthetic technique. The Anaeject® system and the convectional syringe were applied in random order, and the children were divided into two groups depending on how the injection was going to be applied. Different scales wew used, and the patients heart rates were monitored at different points during the treatment. Results: The results were analyzed using a statistical software system (Statgraphics Plus® Version 5.0), and the multifactorial ANOVA technique was used for analyzing the subjective data. The objective data were analyzed using StudentÆs T-test for paired samples. Statistically significant differences were not found (p less than 0.05) with regard to anxiety and pain perceived during the injection. Conclusions: The use of the Anaeject® system does not reduce the pain perceived by the patient during the injection when compared to the conventional syringe system.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Anesthesia, Dental , Dental Anxiety , Pain Measurement , Heart Rate , Syringes
2.
J Am Acad Dermatol ; 58(5): 891-3, 2008 May.
Article in English | MEDLINE | ID: mdl-18313173

ABSTRACT

Primary acute cutaneous infections caused by Serratia marcescens are extremely unusual. Nevertheless, Serratia infections are especially frequent in chronic granulomatous disease, which is a primary immunodeficiency that affects phagocytic cells of the innate immune system. We report a young man without history of infections, who developed multiple dermal abscesses on a leg with chronic lymphoedema attributed to S marcescens. Laboratory investigations showed a delayed partial neutrophilic oxidative function. It is remarkable that the patient did not have any other infections during childhood, when most of the innate immune deficiencies are diagnosed, and he had no history of granulomatous lesions. We hypothesize that the delayed neutrophilic oxidative function could be explained by a partial neutrophilic oxidative function, which could be enough to maintain the patient asymptomatic until this infection.


Subject(s)
Abscess/microbiology , Serratia Infections/microbiology , Serratia marcescens/isolation & purification , Abscess/drug therapy , Acute Disease , Adult , Ciprofloxacin/therapeutic use , Humans , Male , Neutrophils/physiology , Serratia Infections/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...